JP2016533332A5 - - Google Patents

Download PDF

Info

Publication number
JP2016533332A5
JP2016533332A5 JP2016516958A JP2016516958A JP2016533332A5 JP 2016533332 A5 JP2016533332 A5 JP 2016533332A5 JP 2016516958 A JP2016516958 A JP 2016516958A JP 2016516958 A JP2016516958 A JP 2016516958A JP 2016533332 A5 JP2016533332 A5 JP 2016533332A5
Authority
JP
Japan
Prior art keywords
protein
nanoparticle
self
amino acid
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2016516958A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016533332A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/057240 external-priority patent/WO2015048149A1/en
Publication of JP2016533332A publication Critical patent/JP2016533332A/ja
Publication of JP2016533332A5 publication Critical patent/JP2016533332A5/ja
Ceased legal-status Critical Current

Links

JP2016516958A 2013-09-24 2014-09-24 自己集合型ナノ粒子ワクチン Ceased JP2016533332A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361881848P 2013-09-24 2013-09-24
US61/881,848 2013-09-24
PCT/US2014/057240 WO2015048149A1 (en) 2013-09-24 2014-09-24 Self-assembled nanoparticle vaccines

Publications (2)

Publication Number Publication Date
JP2016533332A JP2016533332A (ja) 2016-10-27
JP2016533332A5 true JP2016533332A5 (enExample) 2017-11-02

Family

ID=51662365

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016516958A Ceased JP2016533332A (ja) 2013-09-24 2014-09-24 自己集合型ナノ粒子ワクチン

Country Status (5)

Country Link
US (1) US20150110825A1 (enExample)
EP (1) EP3049107A1 (enExample)
JP (1) JP2016533332A (enExample)
CA (1) CA2925201A1 (enExample)
WO (1) WO2015048149A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9630994B2 (en) 2014-11-03 2017-04-25 University Of Washington Polypeptides for use in self-assembling protein nanostructures
WO2016122414A1 (en) * 2015-01-29 2016-08-04 Agency For Science, Technology And Research Nanocapsules carrying chikungunya-associated peptides
CA3003886A1 (en) * 2015-11-06 2017-05-11 University Of South Alabama Novel platform dna vaccine
EP3374504B1 (en) * 2015-11-09 2025-03-19 CureVac SE Optimized nucleic acid molecules
EP3474893A1 (en) 2016-06-27 2019-05-01 The U.S.A. as represented by the Secretary, Department of Health and Human Services Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens
TWI683826B (zh) * 2016-11-22 2020-02-01 國立臺灣大學 重組rsv抗原
TWI634899B (zh) * 2016-11-22 2018-09-11 國立臺灣大學 包含類b肝病毒顆粒作為佐劑的疫苗組成物
CN110506060B (zh) 2017-03-30 2024-05-07 昆士兰大学 嵌合分子及其用途
EP3606942B1 (en) * 2017-04-04 2025-06-11 University of Washington Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use
CA3071922A1 (en) 2017-08-04 2019-02-07 The Governing Council Of The University Of Toronto Nanoparticle platform for antibody and vaccine delivery
JP2021509400A (ja) * 2018-01-06 2021-03-25 イマージェクス ヴァクシンズ ホールディング リミテッドEmergex Vaccines Holding Limited 複数のフラビウイルスの予防および治療を目的としたmhcクラスi関連ペプチド
CN112088014B (zh) 2018-02-28 2026-03-24 华盛顿大学 自组装纳米结构疫苗
JP7412001B2 (ja) * 2018-06-08 2024-01-12 株式会社モダリス 改変されたCas9タンパク質及びその用途
KR102076917B1 (ko) * 2018-10-25 2020-02-13 연세대학교 산학협력단 자가조립 나노 입자를 제조하기 위한 유전자 재조합 발현 벡터 시스템 및 이를 이용하는 방법
EP4004018A1 (en) 2019-07-24 2022-06-01 GlaxoSmithKline Biologicals SA Modified human cytomegalovirus proteins
CN112439056B (zh) * 2019-08-28 2022-05-31 中国农业科学院生物技术研究所 基于自组装铁蛋白纳米抗原颗粒及由其制备的o型口蹄疫疫苗和应用
WO2021245611A1 (en) 2020-06-05 2021-12-09 Glaxosmithkline Biologicals Sa Modified betacoronavirus spike proteins
US20250101067A1 (en) 2022-01-28 2025-03-27 Glaxosmithkline Biologicals Sa Modified human cytomegalovirus proteins
CN116143949A (zh) * 2023-02-23 2023-05-23 中山大学 一种水痘-带状疱疹病毒疫苗及其制备方法
CN116715780A (zh) * 2023-06-09 2023-09-08 中国人民解放军陆军军医大学 重组铜绿假单胞菌纳米颗粒蛋白及其制备方法和应用
CN117567652B (zh) * 2024-01-19 2024-05-14 北京安百胜生物科技有限公司 一种重组呼吸道合胞病毒颗粒抗原
WO2026104630A1 (en) * 2024-11-15 2026-05-21 Bavarian Nordic A/S A permanent dominant selecton method for generation of recombinant modified vaccinia virus ankara (mva)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060057680A1 (en) * 2004-08-11 2006-03-16 Zheng Xin X Mutant interleukin-15 polypeptides
WO2009033004A1 (en) * 2007-09-07 2009-03-12 Montana State University Protein cages and their uses
US8563002B2 (en) * 2007-12-24 2013-10-22 Glaxosmithkline Biologicals, S.A. Recombinant RSV antigens
WO2010075491A2 (en) * 2008-12-24 2010-07-01 University Of Rochester Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins
RS56748B1 (sr) * 2011-05-13 2018-03-30 Glaxosmithkline Biologicals Sa Pre-fuzioni rsv f antigeni
US20130049342A1 (en) * 2011-08-25 2013-02-28 James Michael Cottrell Trailer chassis hold down system
WO2013044203A2 (en) * 2011-09-23 2013-03-28 THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPTARTMENT OF HEALTH & HUMAN SERVICES Novel influenza hemagglutinin protein-based vaccines
SG10201602434UA (en) * 2011-09-30 2016-05-30 Novavax Inc Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus
EP4421177A3 (en) * 2013-03-13 2024-12-18 The United States of America, as represented by the Secretary, Department of Health and Human Services Prefusion rsv f proteins and their use

Similar Documents

Publication Publication Date Title
JP6957580B2 (ja) 新規多価ナノ粒子に基づくワクチン
JP2015509707A5 (enExample)
Patterson et al. Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza
JP2015524422A5 (enExample)
HRP20191594T1 (hr) Poticanje imunosnog odgovora
JP2013521789A5 (enExample)
JP2015501840A5 (enExample)
Mao et al. Surface display on lactic acid bacteria without genetic modification: strategies and applications
WO2023186170A1 (zh) 一种新冠病毒Delta和Omicron变异株嵌合抗原、其制备方法和应用
JP2015508284A5 (enExample)
JP2014507146A5 (enExample)
JP2012095652A5 (enExample)
JP2016501829A5 (enExample)
JP2012509071A5 (enExample)
JP2014502156A5 (enExample)
JP2012501959A5 (enExample)
JP2014530010A5 (enExample)
JP2015212284A5 (enExample)
JP2015506705A5 (enExample)
JP2012515557A5 (enExample)
JP2016514713A5 (enExample)
JP2018524019A5 (enExample)
JP2010538619A5 (enExample)
JP2014519817A5 (enExample)
Lee et al. Nanoglue: an alternative way to display cell-internalizing peptide at the spikes of hepatitis B virus core nanoparticles for cell-targeting delivery